Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Beckman Coulter Life Sciences Features Genomic, Cellular Solutions at SLAS2013

Published: Wednesday, January 09, 2013
Last Updated: Wednesday, January 09, 2013
Bookmark and Share
Workshops, exhibit complemented by Biomek 4000 Workstation grant contest.

Bringing together genomic and cellular sample preparation with integrated solutions to highlight their Automation with a Human Touch theme, Beckman Coulter Life Sciences will offer two workshops and present workstations addressing a range of applications in booth 921 when SLAS2013 convenes in Orlando, Florida, USA, from January 12-16.

Workshops offered by the company begin on Monday, 14 January (2:00-2:45 p.m., Sarasota 1-3), when Lance B. Price, Ph.D., of George Washington University will present “Quantifying the Public Health Burden of Foodborne Extra-intestinal Pathogenic Escherichia coli.”  Dr. Price is director, Center for Food Microbiology and Environmental Health at the Translational Genomics Research Institute.

On Tuesday, 15 January (12:30–1:45 p.m., Osceola 3-4), “Advanced Process and Data Management Software for Automated Systems” will be led by Michael Kowalski, Ph.D., staff applications scientist, Life Science Automation and Genomics and Tim Sherrill, program manager, Integrated Solutions, Life Science Automation, both with Beckman Coulter Life Sciences.

The new Biomek 4000 Liquid Handling Workstation, the latest iteration in the company’s renowned Biomek product line, will be on display in booth 921, where details will be available about a contest for which the prize is a Biomek 4000 Workstation.  The winner, who will receive a workstation configured for the application described in their entry essay, will be announced on 6 April at the American Association for Cancer Research meeting. Information is also available at www.b4kgrantcontest.com.

Beckman Coulter’s exhibit will feature hands-on applications and software demonstrations performed by a team of scientific experts. Visitors will find setups dedicated to the Biomek 4000 Laboratory Automation Workstation featuring pre-written methods, and the SPRIselect Size Selection Reagent Kit, which speeds and simplifies genomic DNA size selection for next generation sequencing fragment library preparation.  Additionally, innovative workstations and integrated systems for flow cytometry and life science research sample preparation applications will be on display, including new SCARA robotic systems.

“Targeted solutions are at the heart of our automation group’s efforts and directly address the needs of our clients,” said Patrick O’Donnell, Director Americas Marketing, Beckman Coulter Life Sciences.  “We are always excited to be at SLAS, and look forward to once again visiting with scientists and friends.” Visit www.bcilifesciences.com/SLAS for more information on Beckman Coulter’s activities at SLAS2013.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Beckman Coulter Announces Third Annual Kaluza Prizes
ASCB to sponsor the Third Annual ASCB Kaluza Prizes for excellence in graduate student research.
Tuesday, December 08, 2015
New Detection Cartridges Expand Applications of Beckman Coulter’s PARADIGM Platform
Beckman Coulter® introduces four detection cartridges for the PARADIGM Detection Platform, its modular plate reader, adding new capabilities for widely used fluorescence and luminescence applications.
Thursday, September 24, 2009
Automation Set to Boost Global Monoclonal Antibody Production
Abcam plc. and Beckman Coulter, Inc. have announced a major bioscience collaboration – to create one of the world’s most sophisticated, automated systems for the production of monoclonal antibodies for use in research.
Monday, December 24, 2007
Beckman Expands Automated Solutions for Biomedical Research
Beckman Chooses Motoman industrial robot arm for integration with the company’s automated liquid handling solutions.
Tuesday, January 24, 2006
Oxford Symposium Spotlights Beckman Coulter's ProteomeLab™ Technology
Beckman Coulter's ProteomeLab PF 2D provides an automated two-dimensional fractionation system.
Wednesday, November 23, 2005
Beckman Coulter Distribution Agreement With CRi

Friday, February 07, 2003
Beckman Coulter and Phenomenex to Co-Market HPLC Products

Tuesday, August 27, 2002
Scientific News
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
The Need for Speed
Evaluating MALDI-TOF as a high-throughput screening technology for the pharmaceutical industry.
Antarctic Sponge Extract Kills MRSA
New findings may provide opportunity for developing new drugs to fight dangerous bacteria currently highly resistant to treatment.
US-India Collab Finds Molecular Signatures of Severe Malaria
Study may be a significant advancement in understanding the causes of severe malaria.
Novel Way to Prevent Deadly Bacterial Infections
Monash scientists may have found a way to stop deadly bacteria from infecting patients. The discovery could lead to a whole new way of treating antibiotic-resistant “superbugs”
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
An Old-New Weapon Against Emerging Chikungunya Virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.
Using Gene-editing Technology for Faster, Cheaper Antiviral Drug Development
UCLA scientists are working to develop special screening libraries based on a gene-editing technology called CRISPR.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!